Iron Chelating Activity [MoA]: Side Effects & Safety Data for 3 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Iron Chelating Activity [MoA] includes 3 drugs with a combined 14,648 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
3
Drugs in Class
14,648
Combined Reports
All Iron Chelating Activity [MoA] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| DEFERASIROX | Deferasirox | 11,322 | 2,661 | 4,008 | 23.5% |
| DEFERIPRONE | FERRIPROX | 2,487 | 287 | 923 | 11.5% |
| DEFEROXAMINE | Desferal | 839 | 152 | 314 | 18.1% |
Common Side Effects in Iron Chelating Activity [MoA] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Death | 1,844 | 1,830 |
| Diarrhoea | 1,124 | 93 |
| Off label use | 1,105 | 124 |
| Serum ferritin increased | 851 | 127 |
| Nausea | 774 | 70 |
| Sickle cell anaemia with crisis | 748 | 12 |
| Pyrexia | 726 | 134 |
| Haemoglobin decreased | 722 | 118 |
| Malaise | 688 | 109 |
| Vomiting | 678 | 62 |